NUTX Stock Forecast 2025-2026
Distance to NUTX Price Targets
NUTX Price Momentum
🤔 Considering Nutex Health (NUTX)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Latest NUTX Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, NUTX has a bullish consensus with a median price target of $60.00 (ranging from $56.00 to $75.00). Currently trading at $52.41, the median forecast implies a 14.5% upside. This outlook is supported by 3 Buy, 0 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Anthony Vendetti at Maxim Group, projecting a 43.1% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
NUTX Analyst Ratings
NUTX Price Target Range
Latest NUTX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for NUTX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 13, 2025 | Maxim Group | Anthony Vendetti | Buy | Maintains | $75.00 |
| Nov 12, 2024 | Maxim Group | Anthony Vendetti | Buy | Maintains | $50.00 |
| Nov 12, 2024 | Benchmark | Bill Sutherland | Buy | Maintains | $60.00 |
| Sep 18, 2024 | Maxim Group | Anthony Vendetti | Buy | Initiates | $45.00 |
| Aug 21, 2024 | Benchmark | Bill Sutherland | Buy | Maintains | $45.00 |
| Jan 25, 2024 | Benchmark | Bill Sutherland | Buy | Maintains | $1.00 |
| Nov 14, 2023 | Benchmark | Bill Sutherland | Buy | Maintains | $1.50 |
| Aug 29, 2023 | Benchmark | Bill Sutherland | Buy | Reiterates | $2.50 |
| May 17, 2023 | Benchmark | Bill Sutherland | Buy | Maintains | $2.50 |
| Mar 9, 2023 | Benchmark | Bill Sutherland | Buy | Reiterates | $3.00 |
| Dec 23, 2022 | Benchmark | Bill Sutherland | Buy | Initiates | $3.00 |
Nutex Health Inc. (NUTX) Competitors
The following stocks are similar to Nutex Health based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Nutex Health Inc. (NUTX) Financial Data
Nutex Health Inc. has a market capitalization of $248.36M with a P/E ratio of 1.4x. The company generates $292.00M in trailing twelve-month revenue with a -14.1% profit margin.
Revenue growth is +25.6% quarter-over-quarter, while maintaining an operating margin of +12.8% and return on equity of -35.1%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Nutex Health Inc. (NUTX) Business Model
About Nutex Health Inc.
Provides accessible healthcare via micro-hospitals.
Nutex Health Inc. operates and manages micro-hospitals and freestanding emergency rooms across the United States, generating revenue through patient services in emergency care and other medical offerings. The company's focus on underserved communities allows it to tap into a growing demand for accessible healthcare, thereby enhancing its profitability.
The company emphasizes patient-centered care and innovative healthcare delivery, aiming to improve patient outcomes. Nutex Health collaborates with healthcare professionals to enhance service efficiency, positioning itself as a significant player in the evolving healthcare sector.
Company Information
Sector
Healthcare
Industry
Medical Care Facilities
Employees
800
CEO
Dr. Thomas T. Vo M.B.A., M.D.
Country
United States
IPO Year
2013
Website
www.nutexhealth.comNutex Health Inc. (NUTX) Latest News & Analysis
Nutex Health Inc. (NASDAQ: NUTX) updated on its arbitration participation under the No Surprises Act, having contracted a vendor for out-of-network claims recovery as of July 1, 2024.
Nutex Health's involvement in the IDR process under the No Surprises Act highlights its strategy to recover out-of-network claims, potentially improving financial stability and investor confidence.
Nutex Health Inc. (NASDAQ: NUTX) announced that its micro-hospitals received several community awards in Q4 2024, reflecting staff commitment to quality healthcare delivery.
Nutex Health's awards enhance its reputation, potentially attracting more patients and investors, thereby improving financial performance and stock value.
Nutex Health Inc. (NASDAQ: NUTX) opened its fourth hospital, Starkey Ranch ER & Hospital, on December 30, 2024, expanding its network of micro-hospitals to 24 across 11 states.
Nutex Health's expansion with a new hospital enhances its market presence, potentially driving revenue growth and investor confidence in its business model.
Nutex Health Inc. (NASDAQ: NUTX) will present at the 43rd Annual J.P. Morgan Healthcare Conference, highlighting its 24 micro-hospitals and integrated healthcare system.
Nutex Health's participation in a major investment symposium highlights its growth potential and visibility in the healthcare sector, influencing investor sentiment and stock performance.
Nutex Health Inc. (NASDAQ: NUTX) announced the opening of its Milwaukee ER & Hospital, its third facility in 2024, expanding its network of micro hospitals to 23 locations across ten states.
Nutex Health's expansion with a new hospital enhances its market presence and revenue potential, signaling growth and increased competitiveness in the healthcare sector.
Nutex Health Inc. (NASDAQ:NUTX) will hold its Q3 2024 earnings conference call on November 8, 2024, at 10:30 AM ET, featuring key company executives.
Nutex Health's Q3 earnings call provides insights into financial performance and strategic direction, influencing stock valuation and investor sentiment.
Frequently Asked Questions About NUTX Stock
What is Nutex Health Inc.'s (NUTX) stock forecast for 2025?
Based on our analysis of 2 Wall Street analysts, Nutex Health Inc. (NUTX) has a median price target of $60.00. The highest price target is $75.00 and the lowest is $56.00.
Is NUTX stock a good investment in 2025?
According to current analyst ratings, NUTX has 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $52.41. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for NUTX stock?
Wall Street analysts predict NUTX stock could reach $60.00 in the next 12 months. This represents a 14.5% increase from the current price of $52.41. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Nutex Health Inc.'s business model?
Nutex Health Inc. operates and manages micro-hospitals and freestanding emergency rooms across the United States, generating revenue through patient services in emergency care and other medical offerings. The company's focus on underserved communities allows it to tap into a growing demand for accessible healthcare, thereby enhancing its profitability.
What is the highest forecasted price for NUTX Nutex Health Inc.?
The highest price target for NUTX is $75.00 from Anthony Vendetti at Maxim Group, which represents a 43.1% increase from the current price of $52.41.
What is the lowest forecasted price for NUTX Nutex Health Inc.?
The lowest price target for NUTX is $56.00 from at , which represents a 6.8% increase from the current price of $52.41.
What is the overall NUTX consensus from analysts for Nutex Health Inc.?
The overall analyst consensus for NUTX is bullish. Out of 2 Wall Street analysts, 3 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $60.00.
How accurate are NUTX stock price projections?
Stock price projections, including those for Nutex Health Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
